Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro can reduce how well oral contraceptives are absorbed, particularly during the first four weeks of treatment and after each dose increase. This is a real pharmacological concern, not a scare story — and it has a straightforward practical answer. Because Mounjaro slows gastric emptying, the contraceptive pill may pass through your digestive system at a different rate than usual, which can affect how much of the active hormone reaches your bloodstream. These are prescription-only medicines that require a clinical assessment before you start, and the right contraceptive approach for you is part of that conversation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Every dose of an oral contraceptive pill depends on your gut absorbing it at roughly the right speed. Mounjaro works partly by slowing the rate at which your stomach empties its contents, that same mechanism is responsible for the feeling of fullness that makes it effective for weight loss. The side effect is that any oral medicine taken alongside it, including the pill, may sit in your stomach longer or move through your small intestine differently than your body is used to.
The practical consequence is that the amount of oestrogen or progestogen reaching your bloodstream might be lower than the level the pill was designed to deliver. If you want a thorough answer to whether Mounjaro stops the pill from working, our dedicated page walks through the mechanism and what it means for your contraceptive cover in plain terms. This is not a theoretical risk specific to Mounjaro, it follows directly from how the medicine works, and the UK's official guidance treats it as a real one. You can read the NHS's detailed information about tirzepatide on the NHS medicines page for tirzepatide, which covers this interaction explicitly.
The good news is that the concern is time-limited and manageable. It is most relevant at the start of treatment and whenever your prescriber increases your dose, because those are the moments when gastric emptying changes most noticeably. Once your body has adjusted at a given dose level, the effect tends to stabilise.
This is the practical bit. NHS guidance (drawing on the Mounjaro prescribing information and national clinical recommendations) says that women using oral contraceptives should add a reliable non-oral method of contraception for the first four weeks of starting Mounjaro and for four weeks after each dose increase. Condoms are the simplest choice, but anything that does not rely on oral absorption counts. You do not need to stop the pill; you are adding a backup while the new dose settles.
There is a useful one-minute check worth doing right now: look at your Mounjaro dose schedule and note when your next increase is due. If it is within the next month, that is a good moment to make sure you have a non-oral backup method ready before the change happens, not after.
NHS England's guidance on weight-management injections covers this and related points, including a note that if you use oral HRT rather than patches or gels, the same absorption concern applies, and switching to a transdermal form is worth discussing with your GP. That guidance is available on the NHS England weight-management injections page.
If you are curious how this contrasts with the semaglutide picture, our page on the Mounjaro overview sets out the key differences between the two medicines in plain terms.
Knowing about the pill interaction before you start Mounjaro is genuinely useful because it is easy to plan for. This is the kind of thing a prescriber will discuss with you during your consultation, not something you should be discovering six weeks in.
If you are already on Mounjaro and this is news to you, speak to your prescriber or GP promptly rather than stopping either medicine. Stopping your contraception or stopping Mounjaro without clinical input is not the right response. A prescriber can review your current dose stage, how long you have been at it, and what the sensible next step looks like for you specifically.
For people weighing whether to start treatment at all, the interaction rarely tips the balance against it. Most people find a backup method for a few weeks at a time entirely manageable, particularly given what the medicine can achieve over months. Our page on weight-loss treatments covers the full clinical picture and how our consultation process works. If you want to understand how tirzepatide's mechanism compares to other options in practical terms, the tirzepatide overview is a good starting point.
There is a separate question some people have: does Mounjaro itself stop working over time, independent of the contraceptive question. That is a different concern, you can explore it on our page about whether Mounjaro stops working, or read about what happens when Mounjaro appears to stop working after a while. There is also a related question about whether tirzepatide can stop working more broadly, which looks at the evidence on long-term effectiveness and what to do if your results plateau.
Our clinical team reviews every consultation personally, a named prescriber reads your answers, not an automated system. If contraception is relevant to your situation, you can raise it directly in the consultation and get a clear, individual recommendation. Speak to our prescribers to get started.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.